Thrivent Financial for Lutherans’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $136M | Buy |
256,341
+24,849
| +11% | +$11.5M | 0.23% | 91 |
|
|
2026
Q1 | $111M | Buy |
231,492
+106,230
| +85% | +$54.4M | 0.21% | 102 |
|
|
2025
Q4 | $70.4M | Buy |
125,262
+9,318
| +8% | +$5.29M | 0.12% | 187 |
|
|
2025
Q3 | $59.6M | Buy |
115,944
+669
| +0.6% | +$292K | 0.12% | 205 |
|
|
2025
Q2 | $36.2M | Sell |
115,275
-5,859
| -5% | -$1.76M | 0.08% | 281 |
|
|
2025
Q1 | $36.9M | Buy |
121,134
+206
| +0.2% | +$69.3K | 0.08% | 298 |
|
|
2024
Q4 | $40.2M | Buy |
120,928
+106,498
| +738% | +$36.1M | 0.08% | 316 |
|
|
2024
Q3 | $4.82M | Buy |
14,430
+5,484
| +61% | +$2.08M | 0.01% | 942 |
|
|
2024
Q2 | $3.69M | Buy |
8,946
+2,741
| +44% | +$1.09M | 0.01% | 1027 |
|
|
2024
Q1 | $2.51M | Buy |
6,205
+19
| +0.3% | +$6.68K | 0.01% | 1249 |
|
|
2023
Q4 | $1.9M | Sell |
6,186
-10
| -0.2% | -$2.7K | ﹤0.01% | 1402 |
|
|
2023
Q3 | $1.5M | Sell |
6,196
-33,040
| -84% | -$8.45M | ﹤0.01% | 1495 |
|
|
2023
Q2 | $9.42M | Sell |
39,236
-26,424
| -40% | -$5.49M | 0.02% | 664 |
|
|
2023
Q1 | $12.3M | Sell |
65,660
-304,279
| -82% | -$62.9M | 0.03% | 555 |
|
|
2022
Q4 | $78.6M | Buy |
369,939
+218,554
| +144% | +$43.7M | 0.2% | 136 |
|
|
2022
Q3 | $23.8M | Buy |
151,385
+144,323
| +2,044% | +$23M | 0.07% | 350 |
|
|
2022
Q2 | $1.06M | Sell |
7,062
-451
| -6% | -$65.3K | ﹤0.01% | 1680 |
|
|
2022
Q1 | $1.23M | Sell |
7,513
-68
| -0.9% | -$11.2K | ﹤0.01% | 1696 |
|
|
2021
Q4 | $1.65M | Buy |
7,581
+91
| +1% | +$19.1K | ﹤0.01% | 1521 |
|
|
2021
Q3 | $1.42M | Buy |
7,490
+137
| +2% | +$25K | ﹤0.01% | 1595 |
|
|
2021
Q2 | $1.3M | Buy |
7,353
+38
| +0.5% | +$6.56K | ﹤0.01% | 1677 |
|
|
2021
Q1 | $1.2M | Buy |
7,315
+104
| +1% | +$15.9K | ﹤0.01% | 1755 |
|
|
2020
Q4 | $1M | Sell |
7,211
-132
| -2% | -$16.6K | ﹤0.01% | 1761 |
|
|
2020
Q3 | $821K | Sell |
7,343
-15,160
| -67% | -$1.75M | ﹤0.01% | 1690 |
|
|
2020
Q2 | $2.09M | Sell |
22,503
-446
| -2% | -$38K | 0.01% | 1032 |
|
|
2020
Q1 | $1.68M | Buy |
22,949
+1,145
| +5% | +$99.4K | 0.01% | 1026 |
|
|
2019
Q4 | $1.83M | Buy |
21,804
+248
| +1% | +$19.2K | 0.01% | 1097 |
|
|
2019
Q3 | $1.81M | Buy |
21,556
+1,117
| +5% | +$84.4K | 0.01% | 1053 |
|
|
2019
Q2 | $1.34M | Buy |
20,439
+571
| +3% | +$32.9K | ﹤0.01% | 1222 |
|
|
2019
Q1 | $1.17M | Buy |
19,868
+1,457
| +8% | +$87K | ﹤0.01% | 1264 |
|
|
2018
Q4 | $974K | Sell |
18,411
-47,012
| -72% | -$2.58M | ﹤0.01% | 1169 |
|
|
2018
Q3 | $3.92M | Buy |
65,423
+34,997
| +115% | +$1.91M | 0.01% | 709 |
|
|
2018
Q2 | $1.31M | Sell |
30,426
-24,637
| -45% | -$995K | ﹤0.01% | 1093 |
|
|
2018
Q1 | $1.92M | Sell |
55,063
-7,549
| -12% | -$276K | 0.01% | 917 |
|
|
2017
Q4 | $2.27M | Buy |
+62,612
| New | +$2.19M | 0.01% | 868 |
|
Other funds holding MEDP
WA
Thrivent Financial for Lutherans's MEDP Position: Q2 2026 in Review
Thrivent Financial for Lutherans increased its Medpace (MEDP) stake by 11% in Q2 2026, buying an estimated $11.5M and bringing the position to 256,341 shares worth $136M. The position accounts for 0.23% of the portfolio, ranked #91.
Thrivent Financial for Lutherans first reported a position in MEDP in Q4 2017 and has held it in 35 quarters since. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Thrivent Financial for Lutherans held 256,341 shares of Medpace worth $136M as of Q2 2026.
- Thrivent Financial for Lutherans bought 24,849 Medpace shares in Q2 2026, an estimated $11.5M.
- Medpace made up 0.23% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #91 holding.
- Thrivent Financial for Lutherans first reported a position in Medpace in Q4 2017 and has held it in 35 quarters since.
- 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.